How Leqembi and Kisunla address the root cause of dementia
Alzheimer’s disease, the most prevalent form of dementia, currently affects over 7 million individuals aged 65 and above, with projections indicating that this number could nearly double by 2050 as degenerative conditions continue to rise. Recently, two innovative drugs have emerged, showing promise in reducing memory loss and the overall cognitive decline linked to the […]